To determine, in patients with coronavirus disease 2019 (COVID-19) infection, the
associations of pulmonary embolism (PE) with mortality and risk factors for PE as well as the …

Introduction: The severity of COVID-19 may be correlated with the risk of liver injury
development. An increasing number of studies indicate that degrees of hepatotoxicity has …

Background: Epidemiological studies have shown that atrial fibrillation (AF) is a potential
cardiovascular complication of coronavirus disease 2019 (COVID-19). We aimed to perform …

Aims GLP-1RA has many beneficial properties, including anti-inflammatory, anti-
obesogenic, pulmonary protective effects as well as beneficial impact on gut microbiome …

Ivermectin is an FDA‐approved drug for a parasitic disease that has broad antiviral activity.
This study aims to analyse the efficacy of ivermectin in improving the Covid‐19 outcomes …

Vitamin D has many protective properties and potential role against acute lung injury. Low
serum vitamin D is associated with high risk of pneumonia and development of acute …

Background: We provided a comprehensive evaluation of efficacy of available treatments for
coronavirus disease 2019 (COVID-19). Methods: We searched for candidate COVID-19 …

The COVID-19 pandemic has plagued the world for over three years since discovering the
causative virus, SARS-CoV-2, in China. The rampant spread of the virus led to the loss of …

Background Currently, JAK-inhibitors are repurposed for therapy of Covid-19 because of
their ability in restraining immune response, yet the corroboration regarding their advantage …

Background Sarcopenia has been associated with patients' poor quality of life, disability,
and hospitalization. As of today, evidence that highlights the association between …